secondview.blogspot.com
secondview: April 2006
http://secondview.blogspot.com/2006_04_01_archive.html
Hello I am Judit Rius Sanjuan. An IP lawyer working for CPTECH in Washington, DC. Welcome to my professional blog. Thursday, April 27, 2006. Open Letter to Stanford University. While trying to contact Pfizer's Chairman and CEO ( Dr. Henry McKinnell. On the Philippines litigation. We realized he is a Stanford alumnus and member of the Stanford University Graduate School of Business Advisory Council. And not only that, he has been honored by the business school for his "leadership". Rishi Madhok, student.
mistakesaremade.blogspot.com
Mistakes are made: November 2005
http://mistakesaremade.blogspot.com/2005_11_01_archive.html
Tuesday, November 29, 2005. Not True that Public Health Emergencies Necessary for Compulsory Licensing of Patents. In the controveries over compulsory licensing of patents on medicines, news editors, reporters, students, academic researchers and others repeat the untrue assertion that the WTO TRIPS agreement provides for the compulsory licensings of patents only. The most accessible discussion of the TRIPS rules on compulsory licensing of patents for health care inventions is the WTO's recent FAQ. Or for...
mistakesaremade.blogspot.com
Mistakes are made: December 2005
http://mistakesaremade.blogspot.com/2005_12_01_archive.html
Saturday, December 10, 2005. European Commission spin on "delicate issue of compulsory licensing". Below is a press release from the European Commission on negotiations in Europe to implement the provisions for exports of medicines manufactured under a compulsory license. Here are a few things that caught my eye:. I guess the EU negotiators think that negotiating a really restrictive implementation of the already bad decision will delight the WTO negotiators from developing countries. Of course, give...
secondview.blogspot.com
secondview: November 2006
http://secondview.blogspot.com/2006_11_01_archive.html
Hello I am Judit Rius Sanjuan. An IP lawyer working for CPTECH in Washington, DC. Welcome to my professional blog. Thursday, November 09, 2006. Robert L. Joss, Dean of the Stanford Graduate School of Business, answered the Open Letter to Stanford University. Requesting a public inquiry regarding Dr. McKinnell (ex-Pfizer CEO) fitness to serve the Stanford University Graduate School of Business Advisory Council. Find a copy of his letter here. TO: Robert L. Joss. John L. Hennessy. Henry A. McKinnell. Stanf...
secondview.blogspot.com
secondview: September 2006
http://secondview.blogspot.com/2006_09_01_archive.html
Hello I am Judit Rius Sanjuan. An IP lawyer working for CPTECH in Washington, DC. Welcome to my professional blog. Friday, September 22, 2006. A good idea: amending Philippines’s Patent Law. Not all are bad news. At CPTech we are following with great interest the work of the Philippine’s Senate Committees on Trade and Commerce and Health and Demography, chaired by Senator Roxas and Senator Cayetano, respectively. On June 7, these two senators filed Committee Report No. 79. C) Adopting the doctrine of int...
secondview.blogspot.com
secondview: February 2006
http://secondview.blogspot.com/2006_02_01_archive.html
Hello I am Judit Rius Sanjuan. An IP lawyer working for CPTECH in Washington, DC. Welcome to my professional blog. Monday, February 27, 2006. Notes from WIPO PCDA, Feb 24. This were my notes from last friday, Feb 24. Judit Rius, CPTech. The first session of the PCDA finished a few minutes ago. The tangible results of this week of discussions are two documents:. A) A draft summary by the chair with an annex of 45 proposals, from Chile, Colombia, the African Group and the United States; and. Overall, the P...
secondview.blogspot.com
secondview: December 2006
http://secondview.blogspot.com/2006_12_01_archive.html
Hello I am Judit Rius Sanjuan. An IP lawyer working for CPTECH in Washington, DC. Welcome to my professional blog. Tuesday, December 19, 2006. Pfizer threatens another philippine generic company with litigation to stop legal competition. Pfizer is striking the Philippines generic industry again. Pfizer prices (under brandname Olmetec):. 10mg strength PHP 38.94 per tablet. 20mg strength PHP 47.20 per tablet. 40mg strength PHP 70.72 per tablet. OEP Prices (under brandname Olmezar):. 1 They have 5 years of ...